As there are limited data available concerning the prognostic impact of MEF2D-r in ALL, we conducted an international study via the Ponto di Legno Childhood Leukemia Working Group to describe the clinical characteristics and outcome of patients with BCP-ALL and MEF2D-r. This evidence concerns the gene MEF2D and acute lymphoblastic leukemia.